Brain iron pathways and their relevance to Parkinson's disease
暂无分享,去创建一个
D. Berg | P. Riederer | K. Double | M. Gerlach | L. Zecca | M. Youdim | M. B. H. Youdim | G. Becker | Georg Becker | Peter Riederer | Manfred Gerlach | Luigi Zecca | Moussa B. H. Youdim
[1] M Gallorini,et al. Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes , 2001, Journal of neurochemistry.
[2] G Becker,et al. Relationship of substantia nigra echogenicity and motor function in elderly subjects , 2001, Neurology.
[3] P. Riederer,et al. Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? , 2000, Journal of Chemical Neuroanatomy.
[4] E. Broussolle,et al. Clinical report of three patients with hereditary hemochromatosis and movement disorders , 2000, Movement disorders : official journal of the Movement Disorder Society.
[5] J. Tolmie,et al. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation , 2000 .
[6] L. Greene,et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] C. Horbinski,et al. Differential Localization of Divalent Metal Transporter 1 with and without Iron Response Element in Rat PC12 and Sympathetic Neuronal Cells , 2000, The Journal of Neuroscience.
[8] H. Schipper,et al. Role of heme oxygenase‐1 in the regulation of manganese superoxide dismutase gene expression in oxidatively‐challenged astroglia , 2000, Journal of cellular physiology.
[9] L. Benson,et al. Iron-dependent self-assembly of recombinant yeast frataxin: implications for Friedreich ataxia. , 2000, American journal of human genetics.
[10] John Hardy,et al. The A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity , 2000, The Journal of Neuroscience.
[11] F. Kishi,et al. Human NRAMP2/DMT1, Which Mediates Iron Transport across Endosomal Membranes, Is Localized to Late Endosomes and Lysosomes in HEp-2 Cells* , 2000, The Journal of Biological Chemistry.
[12] S. Abboud,et al. A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.
[13] M. Youdim,et al. Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases. , 2000, Cellular and molecular biology.
[14] T. Wada,et al. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] E. Morgan,et al. Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. , 2000, Cellular and molecular biology.
[16] B. Bergamasco,et al. Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients. , 2000, Biochimica et biophysica acta.
[17] P. Ponka,et al. Effects of Interferon-γ and Lipopolysaccharide on Macrophage Iron Metabolism Are Mediated by Nitric Oxide-induced Degradation of Iron Regulatory Protein 2* , 2000, The Journal of Biological Chemistry.
[18] Y. Agid,et al. Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.
[19] M. Núñez,et al. Overexpression of the Ferritin Iron-responsive Element Decreases the Labile Iron Pool and Abolishes the Regulation of Iron Absorption by Intestinal Epithelial (Caco-2) Cells* , 2000, The Journal of Biological Chemistry.
[20] J. Feder. The hereditary hemochromatosis gene (HFE) , 1999, Immunologic research.
[21] S. Mandel,et al. The Pivotal Role of Iron in NF‐κB Activation and Nigrostriatal Dopaminergic Neurodegeneration: Prospects for Neuroprotection in Parkinson's Disease with Iron Chelators , 1999, Annals of the New York Academy of Sciences.
[22] H. Beug,et al. Post-transcriptional control via iron-responsive elements: the impact of aberrations in hereditary disease. , 1999, Mutation research.
[23] M. Herman,et al. Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging. , 1999, Neurotoxicology.
[24] N. Andrews. The iron transporter DMT1. , 1999, The international journal of biochemistry & cell biology.
[25] E. Morgan,et al. Iron-independent neuronal expression of transferrin receptor mRNA in the rat. , 1999, Brain research. Molecular brain research.
[26] M E Conrad,et al. Iron absorption and transport. , 1999, The American journal of the medical sciences.
[27] D. Haile,et al. Regulation of genes of iron metabolism by the iron-response proteins. , 1999, The American journal of the medical sciences.
[28] D. Dexter,et al. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment. , 1999, Advances in experimental medicine and biology.
[29] J. Gitlin,et al. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[30] G Becker,et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound , 1999, Neurology.
[31] Z. Wszolek,et al. Reduced expression of the G209A α‐synuclein allele in familial parkinsonism , 1999 .
[32] J. Snaedal,et al. Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. , 1999, Pharmacology & toxicology.
[33] M. G. Bridelli,et al. The structure of neuromelanin and its iron binding site studied by infrared spectroscopy , 1999, FEBS letters.
[34] G Becker,et al. Iron accumulation in the substantia nigra in rats visualized by ultrasound. , 1999, Ultrasound in medicine & biology.
[35] J Kim,et al. Copper(II)-induced self-oligomerization of alpha-synuclein. , 1999, The Biochemical journal.
[36] T. Lee,et al. Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats , 1999, Neuroscience.
[37] M. Núñez,et al. Transferrin stimulates iron absorption, exocytosis, and secretion in cultured intestinal cells. , 1999, The American journal of physiology.
[38] L. Bernier,et al. Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore , 1999, Journal of neurochemistry.
[39] C. Levenson,et al. Developmental regulation of hepatic ceruloplasmin mRNA and serum activity by exogenous thyroxine and dexamethasone. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[40] C. Ríos,et al. Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease , 1999, Neuroscience Letters.
[41] P D Griffiths,et al. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.
[42] E. Masliah,et al. Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro , 1999 .
[43] W. Sly,et al. Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: increased duodenal expression of the iron transporter DMT1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] L. Fenart,et al. Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier* , 1999, The Journal of Biological Chemistry.
[45] P. Ponka,et al. Cellular iron metabolism. , 1999, Kidney international. Supplement.
[46] S. Grinstein,et al. The Iron Transport Protein NRAMP2 Is an Integral Membrane Glycoprotein That Colocalizes with Transferrin in Recycling Endosomes , 1999, The Journal of experimental medicine.
[47] D. Radisky,et al. The Yeast Frataxin Homologue Mediates Mitochondrial Iron Efflux , 1999, The Journal of Biological Chemistry.
[48] P Z Marmarelis,et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. , 1999, Magnetic resonance imaging.
[49] V. Seshadri,et al. Ceruloplasmin Ferroxidase Activity Stimulates Cellular Iron Uptake by a Trivalent Cation-specific Transport Mechanism* , 1999, The Journal of Biological Chemistry.
[50] J. Yu,et al. Characterization and chromosomal mapping of the human gene for SFT, a stimulator of Fe transport. , 1998, Biochemical and biophysical research communications.
[51] J. Dooley,et al. Monocyte-macrophage ferric reductase activity is inhibited by iron and stimulated by cellular differentiation. , 1998, The Biochemical journal.
[52] J. Feder,et al. Co-trafficking of HFE, a Nonclassical Major Histocompatibility Complex Class I Protein, with the Transferrin Receptor Implies a Role in Intracellular Iron Regulation* , 1998, The Journal of Biological Chemistry.
[53] Jianming Yu,et al. Structural and Functional Analysis of SFT, a Stimulator of Fe Transport* , 1998, The Journal of Biological Chemistry.
[54] G. Minotti,et al. Effect of Reactive Oxygen Species on Iron Regulatory Protein Activity a , 1998, Annals of the New York Academy of Sciences.
[55] P. Riederer,et al. In Vitro Studies of Ferritin Iron Release and Neurotoxicity , 1998, Journal of neurochemistry.
[56] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[57] P. Bjorkman,et al. Crystal Structure of the Hemochromatosis Protein HFE and Characterization of Its Interaction with Transferrin Receptor , 1998, Cell.
[58] J. Kaplan,et al. Iron and copper transport in yeast and its relevance to human disease. , 1998, Trends in biochemical sciences.
[59] U. Muthane,et al. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India , 1998, Annals of neurology.
[60] E. Stopa,et al. Neural Heme Oxygenase-1 Expression in Idiopathic Parkinson's Disease , 1998, Experimental Neurology.
[61] D. M. Penny,et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[62] A. Takeda,et al. Evidence for non‐transferrin‐mediated uptake and release of iron and manganese in glial cell cultures from hypotransferrinemic mice , 1998, Journal of neuroscience research.
[63] Y. Mizuno,et al. Apoptosis in neurodegenerative disorders. , 1998, Internal medicine.
[64] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[65] P. Fox,et al. Role of ceruloplasmin in cellular iron uptake. , 1998, Science.
[66] Jianming Yu,et al. Functional Expression Cloning and Characterization of SFT, a Stimulator of Fe Transport , 1997, The Journal of cell biology.
[67] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[68] R E Burke,et al. Apoptosis in neurodegenerative disorders. , 1997, Current opinion in neurology.
[69] Stephan Nussberger,et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.
[70] S. Young,et al. Ceruloplasmin, transferrin and apotransferrin facilitate iron release from human liver cells , 1997, FEBS letters.
[71] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[72] P Riederer,et al. Iron in the Parkinsonian substantia nigra. , 1997, Movement disorders : official journal of the Movement Disorder Society.
[73] E. Hirsch,et al. The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease , 1997, Brain Research.
[74] M. Mattson,et al. Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons , 1996, Brain Research.
[75] J. Gitlin,et al. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. , 1996, Human molecular genetics.
[76] P. Lewitt,et al. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders , 1996, Brain Research.
[77] H. Clevers,et al. Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man , 1996, The Journal of experimental medicine.
[78] H. Feldman,et al. Serum levels of the iron binding protein p97 are elevated in Alzheimer′s disease , 1996, Nature Medicine.
[79] M. Hentze,et al. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[80] H. M. Swartz,et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain , 1996, Neuroscience.
[81] S. LeVine,et al. The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. , 1996, Brain research. Developmental brain research.
[82] H. Schipper. Astrocytes, brain aging, and neurodegeneration , 1996, Neurobiology of Aging.
[83] F. Ye,et al. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance , 1996, Movement disorders : official journal of the Movement Disorder Society.
[84] T. O’Halloran,et al. Iron Metabolism in Eukaryotes—Mars and Venus at It Again , 1996, Science.
[85] W. Jefferies,et al. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin , 1996, Brain Research.
[86] W. Jefferies,et al. Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium , 1996, Brain Research.
[87] Y Agid,et al. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[88] W. Jefferies,et al. A novel iron uptake mechanism mediated by GPI‐anchored human p97. , 1995, The EMBO journal.
[89] P. Riederer,et al. Mössbauer Spectroscopic Studies of Purified Human Neuromelanin Isolated from the Substantia Nigra , 1995, Journal of neurochemistry.
[90] T. Sarna,et al. The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems. , 1995, Biochimica et biophysica acta.
[91] E. Stopa,et al. Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain , 1995, Annals of neurology.
[92] P. Ryvlin,et al. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson's disease. , 1995, Archives of neurology.
[93] R. Ordidge,et al. Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease , 1995, Neurology.
[94] S. Hirai,et al. Activated microglia cause superoxide-mediated release of iron from ferritin , 1995, Neuroscience Letters.
[95] H. Schipper,et al. A Cellular Stress Model for the Sequestration of Redox‐Active Glial Iron in the Aging and Degenerating Nervous System , 1995, Journal of neurochemistry.
[96] R. MacGillivray,et al. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[97] G Becker,et al. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography , 1995, Neurology.
[98] J. Edwardson,et al. Transferrin receptors in the Parkinsonian midbrain , 1994, Neuropathology and applied neurobiology.
[99] P. Riederer,et al. Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? , 1994, Journal of neurochemistry.
[100] K. Jellinger,et al. Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease , 1994, Neuroscience Letters.
[101] S. Benkovic,et al. Isoforms of ferritin have a specific cellular distribution in the brain , 1994, Journal of neuroscience research.
[102] D. Radice,et al. Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain , 1994, Journal of neurochemistry.
[103] Y. Wada,et al. Studies on familial hypotransferrinemia: unique clinical course and molecular pathology. , 1993, American journal of human genetics.
[104] P. Boesiger,et al. T2 relaxation time in patients with Parkinson's disease , 1993, Neurology.
[105] F. Real,et al. Glycosyl phosphatidylinositol membrane anchoring of melanotransferrin (p97): apical compartmentalization in intestinal epithelial cells. , 1993, Journal of cell science.
[106] R. Klausner,et al. Regulating the fate of mRNA: The control of cellular iron metabolism , 1993, Cell.
[107] R. Simpson,et al. Rate of 59Fe Uptake into Brain and Cerebrospinal Fluid and the Influence Thereon of Antibodies Against the Transferrin Receptor , 1993, Journal of neurochemistry.
[108] C. W. Olanow,et al. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.
[109] K. Jellinger,et al. Iron‐Melanin Complex in Substantia Nigra of Parkinsonian Brains: An X‐Ray Microanalysis , 1992, Journal of neurochemistry.
[110] C. Morris,et al. Uptake and Distribution of Iron and Transferrin in the Adult Rat Brain , 1992, Journal of neurochemistry.
[111] C. Olanow. Magnetic resonance imaging in parkinsonism. , 1992, Neurologic clinics.
[112] H. Baker,et al. Human melanotransferrin (p97) has only one functional iron‐binding site , 1992, FEBS letters.
[113] E. Parati,et al. The chemical characterization of melanin contained in substantia nigra of human brain. , 1992, Biochimica et biophysica acta.
[114] J. Serody,et al. Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation. , 1991, Journal of immunology.
[115] P. Riederer,et al. Iron‐Melanin Interaction and Lipid Peroxidation: Implications for Parkinson's Disease , 1991, Journal of neurochemistry.
[116] C D Marsden,et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. , 1991, Brain : a journal of neurology.
[117] Birgens Hs. The interaction of lactoferrin with human monocytes. , 1991 .
[118] W. Gibb,et al. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[119] L. Schiaffonati,et al. Expression of the genes for the ferritin H and L subunits in rat liver and heart. Evidence for tissue-specific regulations at pre- and post-translational levels. , 1991, The Biochemical journal.
[120] H J Gundersen,et al. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[121] J. Connor,et al. Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains , 1990, Journal of neuroscience research.
[122] L. Davidson,et al. Fe-saturation and proteolysis of human lactoferrin: effect on brush-border receptor-mediated uptake of Fe and Mn. , 1989, The American journal of physiology.
[123] D. Rice,et al. Structure of human lactoferrin: crystallographic structure analysis and refinement at 2.8 A resolution. , 1989, Journal of molecular biology.
[124] C. Marsden,et al. Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease , 1989, Journal of neurochemistry.
[125] E. Mukai,et al. [Magnetic resonance imaging of parkinsonism]. , 1989, Rinsho shinkeigaku = Clinical neurology.
[126] Peter Riederer,et al. Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.
[127] S. Aust,et al. Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. , 1989, The Journal of biological chemistry.
[128] W. Banks,et al. Studies of the slow bidirectional transport of iron and transferrin across the blood-brain barrier , 1988, Brain Research Bulletin.
[129] E. Schon,et al. Nonidentical distribution of transferrin and ferric iron in human brain , 1988, Neuroscience.
[130] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.
[131] Y. Yamada,et al. Lactoferrin binding by leukemia cell lines. , 1987, Blood.
[132] B. Halliwell,et al. Iron and free radical reactions: two aspects of antioxidant protection , 1986 .
[133] S. Snyder,et al. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin. , 1986, Science.
[134] David M. A. Mann,et al. Possible role of neuromelanin in the pathogenesis of Parkinson's disease , 1983, Mechanisms of Ageing and Development.
[135] R. Johnston,et al. Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system. , 1981, The Journal of clinical investigation.
[136] J. Hajdu,et al. Proteolysis of human ceruloplasmin. Some peptide bonds are particularly susceptible to proteolytic attack. , 1979, European journal of biochemistry.
[137] S. Murao,et al. HEMOCHROMATOSIS ASSOCIATED WITH BRAIN LESIONS: A DISORDER OF TRACE‐METAL BINDING PROTEINS AND/OR POLYMERS? , 1977, Journal of neuropathology and experimental neurology.
[138] INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .
[139] P. Aisen,et al. Lactoferrin and transferrin: a comparative study. , 1972, Biochimica et biophysica acta.
[140] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[141] R. G. Simpson,et al. The benzidine test for occult blood in faces. , 1952, The Quarterly journal of medicine.
[142] J. Cammermeyer. DEPOSITION OF IRON IN PARAVENTRICULAR AREAS OF THE HUMAN BRAIN IN HEMOCHROMATOSIS , 1947 .
[143] J. Sheldon. The Iron Content of the Tissues in Haemochromatosis, With Special Reference to the Brain , 1927 .
[144] D. Berg,et al. The basal ganglia in haemochromatosis , 2000, Neuroradiology.
[145] Elizabeth C. Theil. Targeting mRNA to regulate iron and oxygen metabolism. , 2000, Biochemical pharmacology.
[146] J. Tolmie,et al. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation. , 2000, Blood.
[147] E. Leibold,et al. Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. , 1999, Gene expression.
[148] F. Jiménez-Jiménez,et al. Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease , 1998, Journal of Neural Transmission.
[149] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[150] T. Shima,et al. Binding of iron to neuromelanin of human substantia nigra and synthetic melanin: an electron paramagnetic resonance spectroscopy study. , 1997, Free radical biology & medicine.
[151] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[152] P. Hof,et al. Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson’s disease cases , 1996, Acta Neuropathologica.
[153] R. Thach,et al. Regulation of iron metabolism: translational effects mediated by iron, heme, and cytokines. , 1995, Annual review of nutrition.
[154] K. Krabbe,et al. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[155] P. Riederer,et al. Intranigral injected iron progressively reduces striatal dopamine metabolism , 1994, Journal of neural transmission. Parkinson's disease and dementia section.
[156] P. Riederer,et al. The enigma of neuromelanin in Parkinson's disease substantia nigra. , 1994, Journal of neural transmission. Supplementum.
[157] G. Mashour,et al. Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease. , 1994, Alzheimer disease and associated disorders.
[158] P Riederer,et al. The neurotoxicity of iron and nitric oxide. Relevance to the etiology of Parkinson's disease. , 1993, Advances in neurology.
[159] C. Marsden,et al. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. , 1993, Advances in neurology.
[160] 望月 秀樹. Iron-melanin complex is toxic to dopaminergic neurons in a nigrostriatal co-culture , 1993 .
[161] H. M. Swartz,et al. Total and paramagnetic metals in human substantia nigra and its neuromelanin , 1993, Journal of neural transmission. Parkinson's disease and dementia section.
[162] C. Marsden,et al. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental lewy body disease , 1992, Annals of neurology.
[163] T. Sarna,et al. Modulation by neuromelanin of the availability and reactivity of metal ions , 1992, Annals of neurology.
[164] K. Jellinger,et al. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease , 1992, Annals of neurology.
[165] J. Connor,et al. Iron regulation in the brain: Histochemical, biochemical, and molecular considerations , 1992, Annals of neurology.
[166] G. Cesareni,et al. Structural and functional studies of human ferritin H and L chains. , 1991, Current studies in hematology and blood transfusion.
[167] H. Birgens. The interaction of lactoferrin with human monocytes. , 1991, Danish medical bulletin.
[168] K. Jellinger,et al. Brain iron and ferritin in Parkinson's and Alzheimer's diseases , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[169] P. Riederer,et al. Biochemical fundamentals of Parkinson's disease. , 1988, The Mount Sinai journal of medicine, New York.
[170] J. Drysdale,et al. Human ferritin gene expression. , 1988, Progress in nucleic acid research and molecular biology.
[171] T. Sarna,et al. The effect of melanin on iron associated decomposition of hydrogen peroxide. , 1988, Free radical biology & medicine.
[172] Elizabeth C. Theil. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. , 1987, Annual review of biochemistry.
[173] T. Bothwell,et al. Iron absorption. , 1983, Annual review of medicine.
[174] P. Mcgeer,et al. Aging and extrapyramidal function. , 1977, Archives of neurology.
[175] P. Yates,et al. Lipoprotein pigments--their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. , 1974, Brain : a journal of neurology.
[176] A. Boujnah. [IRON METABOLISM]. , 1964, La Tunisie medicale.
[177] J. Cammermyer. Deposition of iron in paraventricular areas of the human brain in hemochromatosis. , 1947, Journal of neuropathology and experimental neurology.